Chemotherapy for Lymphoma
Links shared publicly online about this topic
Lymphoma on #MDlinx
mdlinx.com — “Lymphoma on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 14, 2010 at 1:34 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Involved-Lesion Radiation Therapy After Chemotherapy in Limited-Stage Head-and-Neck Diffuse Large B Cell Lymph... http://bit.ly/aE1wIY #ENT
Lymphoma cancer treatment chemotherapy radiation therapy surgery | Cancer Symptoms
tweetmeme.com — “Lymphoma cancer treatment chemotherapy radiation therapy surgery1. ChemotherapyChemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping the cells from dividing. When chemotherap” View full resource at tweetmeme.com
Most Recently Shared on December 25, 2009 at 2:58 pm By:
Healthcare TweetMeme Health Social Media
Lymphoma cancer treatment chemotherapy radiation therapy surgery | Cancer Symptoms http://retwt.me/1Lf7U (via @businesschina)
Brentuximab vedotin-chemotherapy combination clinical trial for Hodgkin lymphoma announced
news-medical.net — “Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin (SGN-35) in combination with chemotherapy for the treatment of newly diagnosed Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) that is also in single-agent clinical trials, including a pivotal trial for relapsed and refractory Hodgkin lymphoma and a phase II trial for systemic anaplasti” View full resource at news-medical.net
Most Recently Shared on February 4, 2010 at 6:52 am By:
News-Medical.Net Oncology and Health News
Oncology News: Brentuximab vedotin-chemotherapy combination clinical trial for Hodgkin lymphoma announced: Seattle... http://bit.ly/abRd8s
Oncology Medical News about Drug Therapy Lymphoma Stem Cell Transplantation
mdlinx.com — “Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: A meta-analysis” View full resource at mdlinx.com
Most Recently Shared on April 15, 2010 at 11:24 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on ... http://bit.ly/cWbHFQ #oncology
Oncology Article | Lymphoma
mdlinx.com — “High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas : A Norwegian multi centre phase II study” View full resource at mdlinx.com
Most Recently Shared on January 31, 2011 at 2:29 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
High dose chemotherapy with autologous stem cell support for patients with histologically transformed ... http://bit.ly/dHVWba #oncology
Oncology Article | Lymphoma
mdlinx.com — “Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses” View full resource at mdlinx.com
Most Recently Shared on January 6, 2011 at 2:57 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a int... http://bit.ly/i6tTG3 #oncology
Oncology Article | burkitt lymphoma
mdlinx.com — “Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic burkitt lymphoma/leukemia” View full resource at mdlinx.com
Most Recently Shared on September 16, 2011 at 11:38 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free surviv... http://t.co/JTDy29Ik #oncology
Lymphoma Patients Benefit From Exercise
medicalnewstoday.com — “A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found.The Healthy Exercise for Lymphoma Patients (H” View full resource at medicalnewstoday.com
Most Recently Shared on October 28, 2009 at 2:58 pm By:
MNT Psychology News Health News
Lymphoma Patients Benefit From Exercise: A healthy dose of exercise is good medicine, even for lymphoma patient.. http://bit.ly/qI84k
Lymphoma Patients Benefit From Exercise
medicalnewstoday.com — “A healthy dose of exercise is good medicine, even for lymphoma patients receiving chemotherapy, University of Alberta researchers have found.The Healthy Exercise for Lymphoma Patients (H” View full resource at medicalnewstoday.com
Most Recently Shared on October 28, 2009 at 2:11 pm By:
psychiatryrounds Support and Psychiatry
Lymphoma Patients Benefit From Exercise: A healthy dose of exercise is good medicine, even for lymphoma patient.. http://bit.ly/D6r2r
Oncology Article | Lymphoma
mdlinx.com — “Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone” View full resource at mdlinx.com
Most Recently Shared on December 30, 2010 at 6:22 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgica... http://bit.ly/hNJLtd #oncology
Oncology Article | Lymphoma Anthracyclines
mdlinx.com — “Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy” View full resource at mdlinx.com
Most Recently Shared on August 17, 2011 at 1:01 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthrac... http://t.co/scjTh14 #oncology
Oncology Article | Lymphoma
mdlinx.com — “CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab” View full resource at mdlinx.com
Most Recently Shared on January 14, 2011 at 10:16 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemother... http://bit.ly/dOMLoU #oncology
Oncology Article | Lymphoma
mdlinx.com — “Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma” View full resource at mdlinx.com
Most Recently Shared on January 18, 2011 at 5:18 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Dr Corrado Tarella just commented on: Risk Factors for the Development of Secondary Malignancy After... http://bit.ly/fsA2L6 #authorcmnt
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Healthcare TweetMeme
Tracking Twitter Healthcare Memes from TweetMeme
-
News-Medical.Net
Stay up to date with the latest Oncology news and research via News-Medical.Net
Advertisement
